HANNAH PARROTTE: Open Payments
NPI 1093557084 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 33 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $143 |
| Indivior Inc. | 6 | $115 |
| Boston Scientific Corporation | 1 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Astellas Pharma US Inc | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ViiV Healthcare Company | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Gilead Sciences, Inc. | 1 | $32 |
Products named: REPATHA, SUBLOCADE, General - Pain Management, CAPLYTA, Veozah, REXULTI, APRETUDE, AIRSUPRA.
Industry payments across CO — which companies pay providers there.
